2017
DOI: 10.1002/adfm.201770220
|View full text |Cite
|
Sign up to set email alerts
|

Drug Delivery: ATP‐Responsive Aptamer‐Based Metal–Organic Framework Nanoparticles (NMOFs) for the Controlled Release of Loads and Drugs (Adv. Funct. Mater. 37/2017)

Abstract: Aptamer‐capped, drug‐loaded metal‐organic framework nanoparticles (NOMFs) are synthesized by a click chemistry method by Itamar Willner and co‐workers in article number https://doi.org/10.1002/adfm.201702102. The NOMFs are unlocked by ATP, which is overexpressed in cancer cells, leading to high cytotoxic efficacy and targeted drug release to MDA‐MB‐231 breast cancer cells.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
13
0
1

Year Published

2018
2018
2021
2021

Publication Types

Select...
6

Relationship

2
4

Authors

Journals

citations
Cited by 12 publications
(14 citation statements)
references
References 0 publications
0
13
0
1
Order By: Relevance
“…Willner and coworkers recently extended this nucleic acid conjugation strategy to prepare ATP-responsive aptamer-based nMOFs for the controlled release of chemotherapeutics. [88] They loaded doxorubicin to the channels of Zr-amino-triphenyldicarboxylate nMOF that was previously reported by Lin and coworkers, [80, 89] and then capped the loaded nMOF by hybridization with a complementary nucleic acid, the ATP-aptamer or the ATP-AS1411 hybrid aptamer, in caged configurations. The nMOFs are unlocked in the presence of ATP via the formation of ATP-aptamer complexes to release the drug payloads.…”
Section: Nmofs For Therapeutic Applicationsmentioning
confidence: 99%
See 1 more Smart Citation
“…Willner and coworkers recently extended this nucleic acid conjugation strategy to prepare ATP-responsive aptamer-based nMOFs for the controlled release of chemotherapeutics. [88] They loaded doxorubicin to the channels of Zr-amino-triphenyldicarboxylate nMOF that was previously reported by Lin and coworkers, [80, 89] and then capped the loaded nMOF by hybridization with a complementary nucleic acid, the ATP-aptamer or the ATP-AS1411 hybrid aptamer, in caged configurations. The nMOFs are unlocked in the presence of ATP via the formation of ATP-aptamer complexes to release the drug payloads.…”
Section: Nmofs For Therapeutic Applicationsmentioning
confidence: 99%
“…[87, 89, 134, 135] Zhang and coworkers recently reported cancer cell membrane-camouflaged nMOF nanocomposites to evade the MPS, but this coating increased particle size, thereby causing lung accumulation. [123] In addition, nMOFs have also been modified with various targeting moieties such as folates, [158] integrin-targeting peptides, [51, 73] and aptamers, [88, 194] to increase their uptake in cancer cells. Despite significance progress in surface modifications and active targeting of nMOFs, accurate characterization of coating/targeting efficiency and stability is still an unsolved challenge.…”
Section: Fundamental Challenges and Outlookmentioning
confidence: 99%
“…Not surprisingly, the switchable structural and functional properties of nucleic acids provide a means to develop DNA switches, DNA‐based machines, DNA‐based triggered drug carriers, such as drug‐loaded SiO 2 nanoparticles or microcapsules, programmed reconfiguration of DNA nanostructures, such as origami nanostructures, a well as the triggered reversible aggregation/disaggregation of NPs . Different applications of switchable DNA structures and catalytic nucleic acid assemblies have been suggested, including the development of sensors, controlled drug release from nanocarriers, and the design of chiroplasmonic structures…”
Section: Stimuli‐responsive Dna‐based Hydrogelsmentioning
confidence: 99%
“…Both approaches allow for various ATP‐triggered hierarchical structure formation processes due to the abundant availability of building blocks from the fields of supramolecular chemistry, peptide nanoscience, and DNA/RNA nanotechnology. [ 21,56,58,82 ] However, often such systems show limited selectivity toward ATP over other ATP analogues such as ADP, AMP, GTP, CTP, and UTP. In enzymatic systems, ATP‐dependent reactions are extremely sensitive to the exclusive use of ATP, such as for DNA and RNA ligases, as well as for protein kinases.…”
Section: Molecular Mechanisms For the Integration Of Atp In Self‐assementioning
confidence: 99%